Q1 2025 Liquidia Corp Earnings Call Transcript

May 8, 2025 / 12:30 PM GMT

Release Date Price: €13.86 (+2.44%)

Transcript 10-Q8-K

Key Points

Positve

Liquidia Corp (LQDA) is preparing for the potential launch of its first internally developed commercial product, Erepia, which targets pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.
The company received a favorable court ruling dismissing United Therapeutics' cross claim, removing legal barriers to Erepia's potential final approval.
Liquidia Corp (LQDA) has a strategic focus on developing a best-in-class product profile for Erepia, emphasizing its tolerability, titratability, and ease of use.
The company has a robust sales and medical affairs team with extensive experience in rare diseases, preparing for Erepia's market launch.
Liquidia Corp (LQDA) has established strong relationships with payers, ensuring broad access to Erepia post-launch.

Negative

Revenue for the first quarter of 2025 was only slightly higher than the previous year, indicating limited growth.
The company reported a net loss of $38.4 million for the quarter, an increase from the previous year's loss.
General and administrative expenses increased significantly by 48%, driven by higher personnel costs and legal fees.
There is uncertainty regarding potential legal actions from United Therapeutics, which could impact Erepia's launch.
The company faces challenges in converting patients from existing therapies to its new dry powder formulation, as seen with competitors.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

LQDA.OQ - Liquidia Corp
Q1 2025 Liquidia Corp Earnings Call
May 08, 2025 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome everyone to the Liquidia Corporation first quarter 2025 financial results.

And corporate update conference call. My name is Ari, and I will be your conference operator today.

Currently, all participants are in a listen-only mode. Following the presentation, we will conduct a question and answer session. Intra instructions will be provided at that time for you to queue up for questions. I would like to remind everyone that this conference call is being recorded. I will now hand the call off to Jason Adair, Chief Business Officer.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.